Block, expose, and immunize: triple attack on cancer

Katerina Hönigova1, Katerina Hadrava Vanova2, Martina Raudenska3

  • 1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

PubMed

Insights

Preventing cancer metastasis requires combining immune activation with inhibiting cancer cell spread. This strategy integrates migrastatics, photodynamic therapy (PDT), and intratumoral immunotherapy (ITI) to suppress invasion and boost antitumor immunity.

Area of Science:

  • Oncology
  • Immunotherapy
  • Cancer Therapy

Background:

  • Metastasis prevention is a critical challenge in cancer treatment.
  • Current strategies often lack a combined approach for immune activation and inhibiting cancer cell dissemination.

Purpose of the Study:

  • To propose a multimodal therapeutic strategy integrating migrastatic agents, photodynamic therapy (PDT), and intratumoral immunotherapy (ITI).
  • To outline a comprehensive approach for suppressing cancer cell plasticity, limiting metastasis, and activating antitumor immunity.

Main Methods:

  • Integration of migrastatic agents to inhibit cancer cell motility.
  • Application of photodynamic therapy (PDT) to induce immunogenic cell death and enhance immune recognition.
  • Utilizing intratumoral immunotherapy (ITI) for direct delivery of immune stimulants into tumors.

Main Results:

  • The proposed strategy aims to suppress cancer cell plasticity and reduce the risk of tumor cell dissemination.
  • PDT is expected to promote immunogenic cell death while minimizing damage to healthy tissues.
  • ITI is designed to stimulate robust local antitumor immune responses.

Conclusions:

  • This multimodal approach holds potential for improving outcomes in cancers prone to early invasion.
  • Combining migrastatics, PDT, and ITI offers a comprehensive strategy to combat metastasis.
  • The approach is discussed within the context of current clinical practice for cancer therapy.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
510
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K